Search Results

There are 14357 results for: content related to: Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver

  1. You have full text access to this OnlineOpen article
    The Fibroblast Growth Factor signaling pathway

    Wiley Interdisciplinary Reviews: Developmental Biology

    Volume 4, Issue 3, May/June 2015, Pages: 215–266, David M. Ornitz and Nobuyuki Itoh

    Version of Record online : 13 MAR 2015, DOI: 10.1002/wdev.176

  2. You have free access to this content
    Glycosylation of fibroblast growth factor receptor 4 is a key regulator of fibroblast growth factor 19–mediated down-regulation of cytochrome P450 7A1

    Hepatology

    Volume 52, Issue 2, August 2010, Pages: 656–666, Vassilis Triantis, Eirikur Saeland, Nora Bijl, Ronald P. Oude-Elferink and Peter L. M. Jansen

    Version of Record online : 8 APR 2010, DOI: 10.1002/hep.23708

  3. You have free access to this content
    Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α-hydroxylase gene expression

    Hepatology

    Volume 49, Issue 1, January 2009, Pages: 297–305, Kwang-Hoon Song, Tiangang Li, Erika Owsley, Stephen Strom and John Y. L. Chiang

    Version of Record online : 9 DEC 2008, DOI: 10.1002/hep.22627

  4. You have free access to this content
    FGF21 N- and C-termini play different roles in receptor interaction and activation

    FEBS Letters

    Volume 583, Issue 1, January 05, 2009, Pages: 19–24, Junming Yie, Randy Hecht, Jennifer Patel, Jennitte Stevens, Wei Wang, Nessa Hawkins, Shirley Steavenson, Steve Smith, Dwight Winters, Seth Fisher, Ling Cai, Ed Belouski, Ching Chen, Mark L. Michaels, Yue-Sheng Li, Richard Lindberg, Minghan Wang, Murielle Véniant and Jing Xu

    Version of Record online : 4 DEC 2008, DOI: 10.1016/j.febslet.2008.11.023

  5. You have free access to this content
    Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice

    Hepatology

    Volume 56, Issue 3, September 2012, Pages: 1034–1043, Bo Kong, Li Wang, John Y.L. Chiang, Youcai Zhang, Curtis D. Klaassen and Grace L. Guo

    Version of Record online : 12 JUL 2012, DOI: 10.1002/hep.25740

  6. You have free access to this content
    Targeted inhibition of the FGF19-FGFR4 pathway in hepatocellular carcinoma; translational safety considerations

    Liver International

    Volume 34, Issue 6, July 2014, Pages: e1–e9, Howard R. Mellor

    Version of Record online : 24 JAN 2014, DOI: 10.1111/liv.12462

  7. FGF19 promotes progression of prostate cancer

    The Prostate

    Volume 75, Issue 10, July 1, 2015, Pages: 1092–1101, Hirotaka Nagamatsu, Jun Teishima, Keisuke Goto, Hiroyuki Shikuma, Hiroyuki Kitano, Koichi Shoji, Shogo Inoue and Akio Matsubara

    Version of Record online : 8 APR 2015, DOI: 10.1002/pros.22994

  8. You have free access to this content
    Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development

    International Journal of Cancer

    Volume 136, Issue 10, 15 May 2015, Pages: 2469–2475, Iker Uriarte, M. Ujue Latasa, Simone Carotti, Maite G. Fernandez-Barrena, Oihane Garcia-Irigoyen, Maria Elizalde, Raquel Urtasun, Umberto Vespasiani-Gentilucci, Sergio Morini, Alvaro de Mingo, Montserrat Mari, Fernando J. Corrales, Jesus Prieto, Carmen Berasain and Matias A. Avila

    Version of Record online : 6 NOV 2014, DOI: 10.1002/ijc.29287

  9. You have free access to this content
    Understanding the Physical Interactions in the FGF21/FGFR/β-Klotho Complex: Structural Requirements and Implications in FGF21 Signaling

    Chemical Biology & Drug Design

    Volume 79, Issue 4, April 2012, Pages: 398–410, Junming Yie, Wei Wang, Liying Deng, Lei-Ting Tam, Jennitte Stevens, Michelle M. Chen, Yang Li, Jing Xu, Richard Lindberg, Randy Hecht, Murielle Véniant, Ching Chen and Minghan Wang

    Version of Record online : 1 FEB 2012, DOI: 10.1111/j.1747-0285.2012.01325.x

  10. You have free access to this content
    The human gallbladder secretes fibroblast growth factor 19 into bile: Towards defining the role of fibroblast growth factor 19 in the enterobiliary tract

    Hepatology

    Volume 55, Issue 2, February 2012, Pages: 575–583, Serge J.L.B. Zweers, Klaske A.C. Booij, Mina Komuta, Tania Roskams, Dirk J. Gouma, Peter L.M. Jansen and Frank G. Schaap

    Version of Record online : 19 DEC 2011, DOI: 10.1002/hep.24702

  11. Endocrine fibroblast growth factors as regulators of metabolic homeostasis

    BioFactors

    Volume 35, Issue 1, January/February 2009, Pages: 52–60, Hiroshi Kurosu and Makoto Kuro-o

    Version of Record online : 18 FEB 2009, DOI: 10.1002/biof.12

  12. You have free access to this content
    High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1228–1235, Frank G. Schaap, Niels A. van der Gaag, Dirk J. Gouma and Peter L. M. Jansen

    Version of Record online : 8 DEC 2008, DOI: 10.1002/hep.22771

  13. You have free access to this content
    Expression of FGF19 in human embryonic stem cells

    STEM CELLS

    Volume 31, Issue 11, November 2013, Pages: 2582–2584, Pavel Krejci, Michaela Kunova, Iva Kubikova, Lukas Trantirek, Alois Kozubik and Petr Dvorak

    Version of Record online : 15 NOV 2013, DOI: 10.1002/stem.1493

  14. Fibroblast growth factor 19 meets mammalian target of rapamycin: A mitogenic Tête-à-Tête under consideration

    Hepatology

    Volume 64, Issue 4, October 2016, Pages: 1028–1030, Elisabeth Krones and Martin Wagner

    Version of Record online : 28 JUL 2016, DOI: 10.1002/hep.28691

  15. You have free access to this content
    Molecular subclasses of hepatocellular carcinoma predict sensitivity to fibroblast growth factor receptor inhibition

    International Journal of Cancer

    Volume 138, Issue 6, 15 March 2016, Pages: 1494–1505, Benjamin Schmidt, Lan Wei, Danielle K. DePeralta, Yujin Hoshida, Poh Seng Tan, Xiaochen Sun, Janelle P. Sventek, Michael Lanuti, Kenneth K. Tanabe and Bryan C. Fuchs

    Version of Record online : 9 NOV 2015, DOI: 10.1002/ijc.29893

  16. You have free access to this content
    Pandora's box opens for cholestatic liver disease

    Hepatology

    Volume 63, Issue 3, March 2016, Pages: 694–696, Peter L.M. Jansen and Frank G. Schaap

    Version of Record online : 12 JAN 2016, DOI: 10.1002/hep.28364

  17. Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis

    Molecular Carcinogenesis

    Volume 48, Issue 6, June 2009, Pages: 553–562, Xinqiang Huang, Chaofeng Yang, Chengliu Jin, Yongde Luo, Fen Wang and Wallace L McKeehan

    Version of Record online : 13 NOV 2008, DOI: 10.1002/mc.20494

  18. Klotho suppresses renal tubulo-interstitial fibrosis by controlling basic fibroblast growth factor-2 signalling

    The Journal of Pathology

    Volume 234, Issue 4, December 2014, Pages: 560–572, Xu Guan, Ling Nie, Ting He, Ke Yang, Tangli Xiao, Song Wang, Yunjian Huang, Jingbo Zhang, Junping Wang, Kumar Sharma, Youhua Liu and Jinghong Zhao

    Version of Record online : 30 SEP 2014, DOI: 10.1002/path.4420

  19. You have free access to this content
    The importance of klotho in phosphate metabolism and kidney disease

    Nephrology

    Volume 19, Issue 8, August 2014, Pages: 439–449, Sven-Jean Tan, Edward R Smith, Tim D Hewitson, Stephen G Holt and Nigel D Toussaint

    Version of Record online : 25 JUL 2014, DOI: 10.1111/nep.12268

  20. You have free access to this content
    The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 1, January 2015, Pages: 54–64, J. R. F. Walters, I. M. Johnston, J. D. Nolan, C. Vassie, M. E. Pruzanski and D. A. Shapiro

    Version of Record online : 20 OCT 2014, DOI: 10.1111/apt.12999